Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China
BackgroundCoronavirus Disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus drug treatment. Traditional Chinese Patent Medicines (CPMs) have, however, been widely used to treat COVID-19 in China, and a number of clinical practice results...
Saved in:
Main Authors: | Wei Zhuang (Author), Zheng Fan (Author), Yanqi Chu (Author), Haizheng Wang (Author), Ying Yang (Author), Li Wu (Author), Nan Sun (Author), Ge Sun (Author), Yuqiao Shen (Author), Xiaolan Lin (Author), Guiming Guo (Author), Shengyan Xi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update
by: Wei Zhuang, et al.
Published: (2021) -
Chinese patent medicine - New treatment for tic disorder
by: Junze Geng, et al.
Published: (2022) -
Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
by: Zhi-Hua Yang, et al.
Published: (2021) -
Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
by: Zhi-Hua Yang, et al.
Published: (2021) -
Clinical practice guidelines of Chinese patent medicine in China: A critical review
by: Jian-xin Wang, et al.
Published: (2024)